Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Rodari

Dose Dense Abvd (Dd-Abvd) as First Line Therapy in Early-Stage Unfavorable Hodgkin Lymphoma (Hd): Results of a Phase Ii, Prospective Study by Fondazione Italiana Linfomi

Hematological Oncology

English

Related publications

Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

Journal of Clinical Oncology

English

Brentuximab Vedotin Followed by ABVD +/− Radiotherapy in Patients With Previously Untreated Hodgkin Lymphoma: Final Results of a Pilot Phase II Study

Haematologica

Hematology

2015

English

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma

Advances in Hematology

Hematology

2011

English

Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.

Hematological Oncology

English

Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi

Haematologica

Hematology

2018

English

Rituximab Plus ABVD in Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma

British Journal of Haematology

Hematology

2016

English

Maternal ABVD Chemotherapy for Hodgkin Lymphoma in a Dichorionic Diamniotic Pregnancy: A Case Report

BMC Pregnancy and Childbirth

Gynecology

Obstetrics

2020

English

Excellent Outcome in Hodgkin Lymphoma With ABVD and CMT: A Single-Centre Retrospective Analysis

Hematological Oncology

English

The Elderly Project by the Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Rodari

Dose Dense Abvd (Dd-Abvd) as First Line Therapy in Early-Stage Unfavorable Hodgkin Lymphoma (Hd): Results of a Phase Ii, Prospective Study by Fondazione Italiana Linfomi

Related publications

Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

Brentuximab Vedotin Followed by ABVD +/− Radiotherapy in Patients With Previously Untreated Hodgkin Lymphoma: Final Results of a Pilot Phase II Study

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma

Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.

Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi

Rituximab Plus ABVD in Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Maternal ABVD Chemotherapy for Hodgkin Lymphoma in a Dichorionic Diamniotic Pregnancy: A Case Report

Excellent Outcome in Hodgkin Lymphoma With ABVD and CMT: A Single-Centre Retrospective Analysis

The Elderly Project by the Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma